Brain Targeting by Liposome-Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells

ACS Chemical Neuroscience
Antonietta ArcellaGiulio Caracciolo

Abstract

Temozolomide (TMZ) is the current first-line chemotherapy for treatment of glioblastoma multiforme (GBM). However, similar to other brain therapeutic compounds, access of TMZ to brain tumors is impaired by the blood-brain barrier (BBB) leading to poor response for GBM patients. To overcome this major hurdle, we have synthesized a set of TMZ-encapsulating nanomedicines made of four cationic liposome (CL) formulations with systematic changes in lipid composition and physical-chemical properties. The targeting nature of this nanomedicine is provided by the recruitment of proteins, with natural targeting capacity, in the biomolecular corona (BC) layer that forms around CLs after exposure to human plasma (HP). TMZ-loaded CL-BC complexes were thoroughly characterized by dynamic light scattering (DLS), electrophoretic light scattering (ELS), and nanoliquid chromatography tandem mass spectrometry (nano-LC MS/MS). BCs were found to be enriched of typical BC fingerprints (BCFs) (e.g., Apolipoproteins, Vitronectin, and vitamin K-dependent protein), which have a substantial capacity in binding to receptors that are overexpressed at the BBB (e.g., scavenger receptor class B, type I and low-density lipoprotein receptor). We found that the CL...Continue Reading

References

Jul 19, 2003·The Journal of Biological Chemistry·Dmitri SimbergYechezkel Barenholz
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Dec 1, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Giulio CaraccioloRuggero Caminiti
Oct 20, 2006·The Journal of Physical Chemistry. B·Giulio CaraccioloHeinz Amenitsch
Aug 19, 2008·The Journal of Physical Chemistry. B·Giulio CaraccioloHeinz Amenitsch
Oct 20, 2010·International Journal of Nanomedicine·Torben GjettingHans Skovgaard Poulsen
Jun 22, 2011·Chemical Reviews·Morteza MahmoudiSophie Laurent
Dec 24, 2011·Journal of the American Chemical Society·Carl D WalkeyWarren C W Chan
Jan 24, 2012·Journal of Proteomics·Anna Laura CapriottiAldo Laganà
Apr 10, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yechezkel Barenholz
Jun 20, 2012·European Biophysics Journal : EBJ·Giulio Caracciolo, Heinz Amenitsch
Oct 6, 2012·Advanced Drug Delivery Reviews·Theresa M Allen, Pieter R Cullis
Dec 12, 2012·ACS Nano·Zon W LaiEdouard C Nice
Apr 9, 2013·Cell Adhesion & Migration·Kirat Kumar GangulyAmitava Chatterjee
Jul 31, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Giovanna M BernalBakhtiar Yamini
Aug 7, 2013·Nanomedicine : Nanotechnology, Biology, and Medicine·Guifa XiTadanori Tomita
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark R GilbertMinesh P Mehta
Nov 7, 2013·JAMA : the Journal of the American Medical Association·Antonio Omuro, Lisa M DeAngelis
Jan 7, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Weiwei GaoLiangfang Zhang
Sep 30, 2014·Colloids and Surfaces. B, Biointerfaces·Shahed BehzadiMorteza Mahmoudi
Jan 4, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Giulio Caracciolo
Mar 31, 2015·Nature Nanotechnology·Philip M KellyKenneth A Dawson
Sep 16, 2015·The International Journal of Biochemistry & Cell Biology·Valentina ColapicchioniGiulio Caracciolo
Nov 27, 2015·Biochimica Et Biophysica Acta·Sara PalchettiAldo Laganà
Jan 20, 2016·The International Journal of Biochemistry & Cell Biology·Saeid ZanganehMorteza Mahmoudi
Apr 3, 2016·The International Journal of Biochemistry & Cell Biology·Morteza Mahmoudi
Jun 10, 2016·Nanoscale·S PalchettiG Caracciolo
Aug 28, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Sara PalchettiGiulio Caracciolo
Sep 25, 2016·Trends in Biotechnology·Giulio CaraccioloMorteza Mahmoudi
Dec 27, 2016·Frontiers in Pharmacology·Linda K MooberryAndras G Lacko
Mar 7, 2017·ACS Nano·Claudia CorboEnnio Tasciotti

❮ Previous
Next ❯

Citations

Aug 14, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Steven ZanganehMorteza Mahmoudi
Feb 14, 2019·Analytical and Bioanalytical Chemistry·Anna Laura CapriottiSusy Piovesana
Oct 18, 2018·Clinical and Translational Medicine·Debarati GhoshSonali Bhattacharjee
Feb 1, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Luca DigiacomoGiulio Caracciolo
Dec 19, 2020·Pharmaceutics·Seigo Kimura, Hideyoshi Harashima
Jan 11, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seigo KimuraHideyoshi Harashima
Feb 21, 2021·Drug Discovery Today·Shreya PawarArun K Iyer
Mar 28, 2021·Archivum Immunologiae Et Therapiae Experimentalis·Benita Ortega-BerlangaGabriela Navarro-Tovar
Apr 4, 2021·Pharmaceutics·Giordano PeriniGiulio Caracciolo
Feb 13, 2021·Biomedical Materials·Themis R KyriakidesWendy C Sheu
Apr 5, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Antonio Claudio TedescoLeonardo P Franchi
Jul 7, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·P Soma YasaswiKhushwant S Yadav
Jul 31, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Min YangChangyou Zhan
Aug 8, 2021·Acta Biomaterialia·Natalia OnishchenkoElena Vodovozova
Aug 31, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Leonardo Delello Di FilippoMarlus Chorilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.